3
Announcements
Trials
Browse
Landscape
Status
Recruiting
3
Completed
3
Withdrawn
2
Terminated
1
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma of Lung
1
Interventions
taletrectinib
1
dabrafenib
1
capmatinib
1
brigatinib
1
belagenpumatucel L
1
Suspensions
1
Powders
1
Paclitaxel
1
BID protein, human
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
Lung Neoplasms
×
capmatinib
×
Clear all
NCT04741789
2026-03-16
Managed Access Programs for INC280, Capmatinib
Novartis
No longer available